Roche shares drop 5% as breast cancer drug giredestrant fails clinical trial
Roche shares drop 5% as breast cancer drug giredestrant fails clinical trial
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
JPMorgan beat earnings expectations amid record market revenue, but a downbeat outlook for net interest income hurt the stock.
Most popular articles this week
Latest news from global stock markets, tech giants, and financial sectors
Browse ArticlesBitcoin, Ethereum, altcoins, DeFi, NFTs, and blockchain technology
Browse ArticlesGold, silver, oil, natural gas, and other precious commodities
Browse Articles
Roche shares drop 5% as breast cancer drug giredestrant fails clinical trial
Novartis CEO says U.S. manufacturing expansion will shield from tariffs
AI in drug discovery offers key market opportunities by enhancing drug development efficiency, reducing costs, and improving success rates. It supports per...
Roche's Lunsumio VELO gets FDA accelerated approval for lymphoma
Roche CEO points to higher future drug prices in Switzerland after US deal
Novartis, Roche back US efforts to lower drug costs amid talk of pricing deal